TrovaGene, Inc. (TROV) - Product Pipeline Analysis, 2013 Update - New Report Available
TrovaGene, Inc. (TrovaGene), formally known as Xenomics, Inc. is a development stage molecular diagnostic company. It develops and commercializes proprietary diagnostic technologies for screening and monitoring of various diseases. The company's proprietary urine-based molecular diagnostic tests are used in detection of transrenal DNA (TrDNA) and RNA (TrRNA). The technology can be used in tumor detection and monitoring, prenatal genetic testing, infectious diseases, tissue transplantation, forensic identification, and for patient selection in clinical trials. It out-licenses its transrenal technologies to extend...
View full press release